BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 33201079)

  • 1. Triple Canal Occlusion for the Treatment of Intractable Menière's Disease.
    Gill C; Muzaffar J; Kumar R; Irving R
    Otol Neurotol; 2021 Jan; 42(1):116-120. PubMed ID: 33201079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effects of the Meniett device in Ménière's disease: the Western Australian experience.
    Rajan GP; Din S; Atlas MD
    J Laryngol Otol; 2005 May; 119(5):391-5. PubMed ID: 15949105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term efficacy of triple semicircular canal occlusion in the treatment of intractable Meniere's disease].
    Zhang D; Fan Z; Han Y; Li Y; Wang H
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Sep; 50(9):733-7. PubMed ID: 26696345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple semicircular canal occlusion for the treatment of Ménière's disease.
    Yin S; Chen Z; Yu D; Wu Y; Shi H; Zhou H; Wang J
    Acta Otolaryngol; 2008 Jul; 128(7):739-43. PubMed ID: 18568514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent surgical advances and continued controversies in medically refractory Meniere's disease.
    Lucas JC; Hong RS
    Curr Opin Otolaryngol Head Neck Surg; 2023 Oct; 31(5):325-331. PubMed ID: 37266594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical interventions for Ménière's disease.
    Lee A; Webster KE; George B; Harrington-Benton NA; Judd O; Kaski D; Maarsingh OR; MacKeith S; Ray J; Van Vugt VA; Burton MJ
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD015249. PubMed ID: 36825750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
    Derebery MJ; Fisher LM; Berliner K; Chung J; Green K
    Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
    Minor LB
    Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N; Martín E; García-Tapia R
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmastoid Labyrinthectomy for Menière's Disease: Experience and Outcomes.
    Bergmark RW; Semco RS; Abdul-Aziz D; Rauch SD
    Otol Neurotol; 2020 Dec; 41(10):1413-1418. PubMed ID: 32810022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes of triple semicircular canal plugging for the treatment of intractable Meniere's disease: A single center experience of 361 cases.
    Zhang D; Lv Y; Han Y; Li Y; Li X; Wang J; Song Y; Kong L; Jian H; Fan Z; Wang H
    J Vestib Res; 2019; 29(6):315-322. PubMed ID: 31640108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple semicircular canal occlusion combined with endolymphatic sac decompression: An effective surgical strategy for vertigo control of intractable Meniere's disease.
    Xie B; Wang M; Jiang Y; Xie W; Zhang S; Liu Y
    Clin Otolaryngol; 2022 Mar; 47(2):319-322. PubMed ID: 34407322
    [No Abstract]   [Full Text] [Related]  

  • 13. Endolymphatic sac-vein decompression for intractable Meniere's disease: long term treatment results.
    Ostrowski VB; Kartush JM
    Otolaryngol Head Neck Surg; 2003 Apr; 128(4):550-9. PubMed ID: 12707660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The surgical treatment discussion in intractable Meniere's disease: lateral and posterior semicircular canal plugging with endolymphatic sac decompression].
    Yang F; Song RD; Liu W; Zhang HD; Liu Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(2):127-129. PubMed ID: 29871202
    [No Abstract]   [Full Text] [Related]  

  • 15. Outcome-based assessment of endolymphatic sac decompression for Ménière's disease using the Ménière's disease outcome questionnaire: a review of 90 patients.
    Convert C; Franco-Vidal V; Bebear JP; Darrouzet V
    Otol Neurotol; 2006 Aug; 27(5):687-96. PubMed ID: 16868517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Short-term efficacy of semicircular canal occlusion in the treatment of intractable Meniere's disease].
    Fan ZM; Zhang DG; Han YC; Wang HB
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Aug; 47(8):677-9. PubMed ID: 23141401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Individual management of Meniere's disease and evaluation of functional outcome].
    Chen Y; Yang J; Wu H; Huang Q; Wang Z; Zhang Z
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Aug; 25(16):721-5. PubMed ID: 22070076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC; Minor LB
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilateral Ménière's disease.
    Nabi S; Parnes LS
    Curr Opin Otolaryngol Head Neck Surg; 2009 Oct; 17(5):356-62. PubMed ID: 19617826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sac-vein decompression for intractable Meniere's disease: two-year treatment results.
    Gianoli GJ; Larouere MJ; Kartush JM; Wayman J
    Otolaryngol Head Neck Surg; 1998 Jan; 118(1):22-9. PubMed ID: 9450824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.